Inhibition of nuclear factor κB by IκB superrepressor gene transfer ameliorates ischemia-reperfusion injury after experimental lung transplantation  Takaaki.

Slides:



Advertisements
Similar presentations
Effect of inhaled tacrolimus on ischemia reperfusion injury in rat lung transplant model Johanna Bayer, MD, Nitin A. Das, MD, Clinton E. Baisden, MD, Meenakshi.
Advertisements

Simvastatin ameliorates injury in an experimental model of lung ischemia-reperfusion  Babu V Naidu, FRCS, Steven M Woolley, MRCS, Alexander S Farivar,
Aprotinin improves kidney function and decreases tubular cell apoptosis and proapoptotic signaling after renal ischemia-reperfusion  Ajay Kher, MD, Kirstan.
Induction of apoptosis of lung and esophageal cancer cells treated with the combination of histone deacetylase inhibitor (trichostatin A) and protein.
Simvastatin attenuates cardiac isograft ischemia-reperfusion injury by down-regulating CC chemokine receptor-2 expression  Rong Yin, MD, Jiaquan Zhu,
Inhibition of the MEK/ERK pathway reduces microglial activation and interleukin-1-beta expression in spinal cord ischemia/reperfusion injury in rats 
Annexin V homodimer protects against ischemia reperfusion–induced acute lung injury in lung transplantation  Kohei Hashimoto, MD, Hyunhee Kim, MSc, Hisashi.
One in every 14 patients with early-stage lung cancer is not being treated!  Benny Weksler, MD, MBA  The Journal of Thoracic and Cardiovascular Surgery 
Exogenous surfactant attenuation of ischemia–reperfusion injury in the lung through alteration of inflammatory and apoptotic factors  Bart P. van Putte,
A Histone Deacetylase Inhibitor LBH589 Downregulates XIAP in Mesothelioma Cell Lines Which is Likely Responsible for Increased Apoptosis With TRAIL  James.
Patrick S. Wolf, MD, Heather E. Merry, MD, Alexander S
Simvastatin ameliorates injury in an experimental model of lung ischemia-reperfusion  Babu V Naidu, FRCS, Steven M Woolley, MRCS, Alexander S Farivar,
Gene transfer of heat shock protein 70 protects lung grafts from ischemia-reperfusion injury  Masafumi Hiratsuka, MD, Bassem N Mora, MD, Motoki Yano,
Does the method of lung preservation influence outcome after transplantation? An analysis of 681 consecutive procedures  J. Saravana Ganesh, FRCS, Chris.
Baiya Krishnadasan, MD, Babu V
Yesterday's heroic measure is now standard procedure: Extracorporeal membrane oxygenation as a bridge to lung transplant  Victor van Berkel, MD, PhD 
Induction of apoptosis of lung and esophageal cancer cells treated with the combination of histone deacetylase inhibitor (trichostatin A) and protein.
J. Hunter Mehaffey, MD, Eric J. Charles, MD, Ashish K
Tetramethylpyrazine protects spinal cord and reduces inflammation in a rat model of spinal cord ischemia-reperfusion injury  Lihong Fan, MD, Kunzheng.
Inhaled nitric oxide reduces ischemia-reperfusion injury in rat lungs from non–heart- beating donors  Seiki Takashima, MD, Giovanna Koukoulis, MD, Hidetoshi.
Ex vivo rehabilitation of non–heart-beating donor lungs in preclinical porcine model: Delayed perfusion results in superior lung function  Daniel P. Mulloy,
Superior protection in orthotopic rat lung transplantation with cyclic adenosine monophosphate and nitroglycerin–containing preservation solution  Koichi.
Intrinsic cardiac stem cells are essential for regeneration
Centers for Disease Control “increased-risk” organ donor: Not so risky?  Francis D. Pagani, MD, PhD  The Journal of Thoracic and Cardiovascular Surgery 
Glutathione improves the function of porcine pulmonary grafts stored for twenty-four hours in low-potassium dextran solution  Sebastian-P. Sommer, MD,
Endothelial progenitor cells attenuate the lung ischemia/reperfusion injury following lung transplantation via the endothelial nitric oxide synthase pathway 
Victor van Berkel, MD, PhD 
Interleukin-6 Regulation of Direct Lung Ischemia Reperfusion Injury
Nebulized nitrite protects rat lung grafts from ischemia reperfusion injury  Toshihiro Okamoto, MD, PhD, Xiaoying Tang, MS, Allison Janocha, BS, Caral.
Pretreatment with bone marrow–derived mesenchymal stromal cell–conditioned media confers pulmonary ischemic tolerance  Billanna Hwang, MPH, W. Conrad.
How should we treat air leaks?
Single-dose rosuvastatin ameliorates lung ischemia–reperfusion injury via upregulation of endothelial nitric oxide synthase and inhibition of macrophage.
Chadrick E Denlinger, MD, Michael D Keller, BS, Marty W Mayo, PhD, R
Antisense basic fibroblast growth factor gene transfer reduces early intimal thickening in a rabbit femoral artery balloon injury model  David G. Neschis,
The lord of the rings  Antonio Miceli, MD, PhD 
Experimental study on size matching in a canine living-donor lobar lung transplant model  Takashi Fujita, MD, Hiroshi Date, MD, Kouji Ueda, MD, Itaru.
Decreased lung ischemia-reperfusion injury in rats after preoperative administration of cyclosporine and tacrolimus  B. Krishnadasan, MD, B. Naidu, MBBS,
Endotracheal calcineurin inhibition ameliorates injury in an experimental model of lung ischemia-reperfusion  Steven M. Woolley, MRCS, Alexander S. Farivar,
Tsutomu Tagawa, MDa, Takashi Suda, MDa, Niccolò Daddi, MDa, Benjamin D
The assessment of cost effectiveness and the effectiveness of cost assessment in cardiothoracic surgery  Vinay Badhwar, MD  The Journal of Thoracic and.
A first start for lung transplantation?
Is it really dumb to leave a stump?
Xianyao Xu, MS, Jennifer L. Philip, MD, Md
Validating the use of short interfering RNA as a novel technique for cell-specific target gene knockdown in lung ischemia–reperfusion injury  Heather.
Joseph A. Dearani, MD, Michael J. Ackerman, MD, PhD 
Toll-like receptor 4 mediates ischemia/reperfusion injury of the heart
Impact of low donor to recipient weight ratios on cardiac transplantation  Senthil Nathan Jayarajan, MD, Sharven Taghavi, MD, Eugene Komaroff, PhD, Abeel.
Importance of endothelial nitric oxide synthase for the hypothermic protection of lungs against ischemia-reperfusion injury  Li Zhang, MD, Sanjeev Kumar,
CD4+ T lymphocytes mediate acute pulmonary ischemia–reperfusion injury
Efficient naked plasmid cotransfection of lung grafts by extended lung/plasmid exposure time  Franco D’Ovidio, MD, Niccolò Daddi, MD, Takashi Suda, MD,
Shinya Murakami, MD. , Emile A. Bacha, MD
A fate worse than death  Jennifer S. Lawton, MD 
Hyperoxic ventilation exacerbates lung reperfusion injury
Passing the torch The Journal of Thoracic and Cardiovascular Surgery
Interleukin 10 gene transfection of donor lungs ameliorates posttransplant cell death by a switch from cellular necrosis to apoptosis  Stefan Fischer,
Functional tricuspid pathology: To treat or not to treat
Jason J. Han, MD, Pavan Atluri, MD 
Johanna Bayer, MD, Nitin A. Das, MD, Clinton E
The Journal of Thoracic and Cardiovascular Surgery
Discussion The Journal of Thoracic and Cardiovascular Surgery
Keep it short and sweet  Ian A. Makey, MD, Scott B. Johnson, MD 
The future of cardiac surgery training: A survival guide
Selective cyclooxygenase 2 inhibitor induces indefinite survival of fully allogeneic cardiac grafts and generates CD4+ regulatory cells  Takeshi Yokoyama,
“The more things change…”: The challenges ahead
Adenoviral-mediated uteroglobin gene transfer inhibits neointimal hyperplasia after balloon injury in the rat carotid artery  Robert A. Larson, MD, Mina.
Iloprost to improve surfactant function in porcine pulmonary grafts stored for twenty-four hours in low-potassium dextran solution  Bernhard Gohrbandt,
Toll-like receptor 4 inhibition attenuates ischemia-reperfusion injury in rats: Will it work in human beings?  Chadrick E. Denlinger, MD  The Journal.
Who should decide margin length in pulmonary excision of lung cancer?
Samuel Kim, MD  The Journal of Thoracic and Cardiovascular Surgery 
Commentary: Evaluation of primary graft dysfunction after lung transplantation—It is time to teach an old dog new tricks!  W. Hampton Gray, MD, P. Michael.
Presentation transcript:

Inhibition of nuclear factor κB by IκB superrepressor gene transfer ameliorates ischemia-reperfusion injury after experimental lung transplantation  Takaaki Ishiyama, MD, Sekhar Dharmarajan, MD, Makio Hayama, MD, Hisao Moriya, PhD, Kathleen Grapperhaus, BSc, G. Alexander Patterson, MD  The Journal of Thoracic and Cardiovascular Surgery  Volume 130, Issue 1, Pages 194-201 (July 2005) DOI: 10.1016/j.jtcvs.2005.02.040 Copyright © 2005 The American Association for Thoracic Surgery Terms and Conditions

Figure 1 Time course of NFκB activation in I/R injury after lung transplantation. After 18 hours of cold preservation, donor lung grafts were transplanted into recipients that were killed at 30 minutes and 1, 2, 4, 8, and 24 hours after reperfusion (n = 3 each). At the end of the reperfusion period, the lungs were flushed with 20 mL of cold (4°C) saline solution, and the transplanted lung graft was excised and frozen in liquid nitrogen for the Trans-AM NFκB p65 transcription factor assay. Nuclear extracts were analyzed by this assay to study activation levels of NFκB. NFκB activation occurs as soon as 30 minutes after reperfusion and is maximal between 30 minutes and 4 hours after reperfusion. *P < .05 versus the Normal, 8h, and 24h groups. OD, Optical density; 18hCP, 18 hours of cold preservation. The Journal of Thoracic and Cardiovascular Surgery 2005 130, 194-201DOI: (10.1016/j.jtcvs.2005.02.040) Copyright © 2005 The American Association for Thoracic Surgery Terms and Conditions

Figure 2 NFκB activation and apoptosis induction after cold preservation and transplantation. Three lungs were flushed with 20 mL of cold (4°C) saline solution, were harvested, and underwent cold preservation alone at 4°C for 18 hours without transplantation. Groups of 3 rats were transplanted with lungs stored at 4°C for 1, 6, 12, and 18 hours by using the modified cuff technique for left lung transplantation. All lungs were sampled after 2 hours of reperfusion. A, The activity of NFκB in the lower third of the lung was analyzed as described in the “Materials and Methods” section. NFκB is activated by the process of transplantation or reperfusion alone, and there is no significant activation of NFκB during cold preservation. *P < .05 versus the Normal and 18hCP groups. B, Induction of apoptotic cell death in the middle third of the lung was measured as described in the “Materials and Methods” section. Apoptosis is minimal after cold preservation alone or reperfusion after minimal cold preservation (1 hour), but apoptotic cell death becomes significantly upregulated after reperfusion after 6 hours of cold preservation. *P < .05 versus the Normal, 18hCP, and 1h groups. OD, Optical density; 18hCP, 18 hours of cold preservation. The Journal of Thoracic and Cardiovascular Surgery 2005 130, 194-201DOI: (10.1016/j.jtcvs.2005.02.040) Copyright © 2005 The American Association for Thoracic Surgery Terms and Conditions

Figure 3 The influence of IκBSR gene transfection on NFκB activation in lung I/R injury. Male Fischer 344 rats were divided into 2 groups according to the transfecting vector. IκB-treated donors (n = 6) received Ad5IκBSR, and β-gal-treated donors (n = 6) received Ad5LacZ. Forty-eight hours after transfection, donor lungs were harvested and preserved for 18 hours at 4°C and then implanted into isogeneic recipients. Recipient rats were killed, and lung grafts were assessed 2 hours after transplantation. Two hours after reperfusion, the lungs were flushed with 20 mL of cold (4°C) saline solution, and the lung graft was excised and divided into sections. NFκB activity was measured as described in the “Materials and Methods” section. NFκB activation was significantly reduced in lungs transfected with IκB. *P < .05 versus β-gal. The Journal of Thoracic and Cardiovascular Surgery 2005 130, 194-201DOI: (10.1016/j.jtcvs.2005.02.040) Copyright © 2005 The American Association for Thoracic Surgery Terms and Conditions

Figure 4 The influence of IκBSR gene transfection on lung function in I/R injury. Male Fischer 344 rats were divided into 3 groups according to the transfecting vector. IκB-treated donors (n = 5) received Ad5IκBSR, β-gal-treated donors (n = 5) received Ad5LacZ, and saline-treated donors (n=5) received vehicle alone (isotonic sodium chloride solution). Forty-eight hours after transfection, donor lungs were harvested and preserved for 18 hours at 4°C and then implanted into isogeneic recipients. Recipient rats were killed, and lung grafts were assessed 24 hours after transplantation, as described in the “Materials and Methods” section. Isolated graft oxygenation was significantly improved in IκB-treated lungs compared with in β-gal- or saline-treated lungs (A). The middle third of the lung graft was frozen in liquid nitrogen for myeloperoxidase activity assay (B). Myeloperoxidase activity was lower in IκB-treated lungs than in either of the control groups. The lower third of the graft was weighed, dried at 80°C for 48 hours, and then reweighed for calculation of the wet/dry weight ratio (C). Wet/dry weight ratios of IκB-treated lungs were lower than those of β-gal-treated or saline-treated lungs. A, *P < .05 versus IκBSR. B, *P = not significant versus IκBSR. C, *P = not significant versus IκBSR. MPO, Myeloperoxidase; OD, optical density. The Journal of Thoracic and Cardiovascular Surgery 2005 130, 194-201DOI: (10.1016/j.jtcvs.2005.02.040) Copyright © 2005 The American Association for Thoracic Surgery Terms and Conditions

Figure 5 The influence of IκBSR gene transfection on apoptosis induction in lung I/R injury. A, Apoptotic cell death was measured as described in the “Materials and Methods” section by using the same lung samples as used in Figure 3. Apoptotic cell death was significantly reduced in IκB-treated lungs compared with in β-gal-treated control lungs. *P < .05 versus β-gal. B, Active caspase-3 activity, a marker for apoptotic cell death, was identified as described in the “Materials and Methods” section. Staining for caspase-3 was significantly less in IκB-treated lungs than in β-gal-treated control lungs, histologically confirming quantitative results obtained by means of enzyme-linked immunosorbent assay. OD, Optical density. The Journal of Thoracic and Cardiovascular Surgery 2005 130, 194-201DOI: (10.1016/j.jtcvs.2005.02.040) Copyright © 2005 The American Association for Thoracic Surgery Terms and Conditions